Avanza Fonder’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
2,458
-4,076
-62% -$847K 0.01% 374
2026
Q1
$1.38M Hold
6,534
0.04% 312
2025
Q4
$1.34M Sell
6,534
-17,480
-73% -$3.29M 0.03% 326
2025
Q3
$3.77M Buy
24,014
+3,525
+17% +$545K 0.1% 168
2025
Q2
$3.44M Sell
20,489
-4,403
-18% -$653K 0.1% 166
2025
Q1
$3.45M Sell
24,892
-465
-2% -$59.3K 0.11% 165
2024
Q4
$3M Buy
+25,357
New +$2.96M 0.09% 186

Other funds holding CAH

Avanza Fonder's CAH Position: Q2 2026 in Review

Avanza Fonder reduced its Cardinal Health (CAH) stake by 62% in Q2 2026, selling an estimated $847K and leaving 2,458 shares worth $584K. The position accounts for 0.01% of the portfolio, ranked #374.

Avanza Fonder first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.77M in Q3 2025. 499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Avanza Fonder held 2,458 shares of Cardinal Health worth $584K as of Q2 2026.
  • Avanza Fonder sold 4,076 Cardinal Health shares in Q2 2026, an estimated $847K.
  • Cardinal Health made up 0.01% of Avanza Fonder's portfolio in Q2 2026, its #374 holding.
  • Avanza Fonder first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Cardinal Health position peaked at $3.77M in Q3 2025.
  • 499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.